Not currently recruiting at UCLA
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Summary
- Eligibility
- for people ages 40-85 (full criteria)
- Location
- at Los Angeles 5368361, California 5332921 and other locations
- Dates
- study startedstudy ends around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Biohaven Therapeutics Ltd.
- ID
- NCT06976268
- Phase
- Phase 2/3 Parkinson's Disease Research Study
- Study Type
- Interventional
- Participants
- Expecting 550 study participants
- Last Updated